Incretin analogues
Long chain incretin analogues and their blends, lyophilised, with lot documentation.
Incretin analogues
Cagrilintide + Semaglutide
- Purity
- ≥ 99%
- Sizes
- 2.5 mg + 2.5 mg to 10 mg + 10 mg
Incretin analogues
Retatrutide + Cagrilintide
- Purity
- ≥ 99%
- Sizes
- 5 mg + 5 mg to 10 mg + 10 mg
What the incretin receptors are
The section is named after a small family of receptors rather than after one molecule. The GLP-1 receptor and the GIP receptor, together with the glucagon receptor that sits beside them, belong to class B1 of the G protein coupled receptors: seven helices crossing the membrane and, in front of them, a large extracellular domain. A peptide ligand of this class binds in two steps. The back half of the chain is held by the extracellular domain, which anchors it, and the first residues then reach down into the helical bundle. That two part contact is the reason the ligands here cannot be short.
Single, dual and triple designs
A single receptor agonist is one chain shaped to be recognised by one of those receptors. A dual agonist is one chain carrying features that two of them accept, and a triple agonist one chain accepted by three. Nothing is mixed to achieve it: the design sits inside a single sequence, residue by residue. Semaglutide, Liraglutide and Dulaglutide are catalogued as single receptor designs, Tirzepatide as a design directed at the GIP and GLP-1 receptors, Mazdutide and Survodutide at the GLP-1 and glucagon receptors, and Retatrutide at all three. Cagrilintide and Eloralintide come from the neighbouring amylin receptor family and are catalogued here because they are handled alongside the others.
Long chains, and what that means at the bench
The recorded masses set the scale: Semaglutide at 4113.6 g/mol, Retatrutide at 4731.3, Tirzepatide at 4813.5. These are chains of roughly forty residues, strongly polar, and several of them also carry that fatty acid tail. Two habits follow. The dry cake takes up moisture from the air, so a vial is left to reach room temperature before the seal is broken. And at low concentration a share of the material settles on the wall of the plastic it is held in, which is worth allowing for when a dilution is planned. Work the volume out before opening anything, with the concentration calculator if it helps, and choose the solvent first: bacteriostatic water for a vial sampled on several occasions, sterile water for one that is used up in a single session.
What the section holds
Twelve catalogue entries, all supplied lyophilised in sealed vials. Nine single peptides, and three two component vials freeze dried together: Cagrilintide + Semaglutide, Retatrutide + Cagrilintide and Tirzepatide + Cagrilintide. Fill weights run from 2 mg upwards, the same material under the same specification in every size. Release follows one rule for the whole section, described under quality. These are chemical reagents: not medicinal products, not food, not cosmetics, and not intended for consumption or for administration to humans or animals. Waste and local handling follow the rules of your institution and the country you work in. The terms of supply are set out under research use only.
Frequently asked questions
What is the difference between a dual agonist and two peptides in one vial?
A dual agonist is one chain. The features that two receptors recognise are written into a single sequence, so there is one molecule, one molar mass and one peak to look for in a chromatogram. A two component vial is something else: two separate peptides freeze dried together, named with a plus sign, as in Cagrilintide + Semaglutide. There the ratio is fixed by the fill weights printed on the vial and cannot be changed afterwards, since the whole cake goes into solution at once.
Why do solutions of these peptides foam when the vial is shaken?
Several members of the group carry a fatty acid chain on a side chain, so one part of the molecule prefers water and another avoids it. Material of that kind collects at the boundary between liquid and air, and shaking makes a great deal of that boundary. Foam is therefore peptide sitting at the surface rather than peptide in solution. Run the solvent down the inside wall of the vial, let it stand, then swirl until the liquid has cleared.
What analytical documentation is held for a lot?
Every lot is released against a purity specification of 99% or higher measured by reversed phase HPLC, with identity confirmed by mass spectrometry. Quote the lot number printed on the vial and the analytical documentation held for that lot can be retrieved against it.